Wells Fargo’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SMTI
SWM
Wells Fargo's SMTI Position: Q2 2026 in Review
Wells Fargo increased its Sanara MedTech (SMTI) stake by 179% in Q2 2026, buying an estimated $40.9K and bringing the position to 3,079 shares worth $72.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5616.
Wells Fargo first reported a position in SMTI in Q4 2020 and has held it in 23 quarters since. The position peaked at $77.6K in Q4 2025. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.
- Wells Fargo held 3,079 shares of Sanara MedTech worth $72.6K as of Q2 2026.
- Wells Fargo bought 1,977 Sanara MedTech shares in Q2 2026, an estimated $40.9K.
- Sanara MedTech made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5616 holding.
- Wells Fargo first reported a position in Sanara MedTech in Q4 2020 and has held it in 23 quarters since.
- Wells Fargo's Sanara MedTech position peaked at $77.6K in Q4 2025.
- 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.